← Eichor
Condition: Nafld Cirrhosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nafld Cirrhosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Phase 2 · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06599918Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
Phase N/A · 1 location(s) · German Diabetes Center · NCT05046483A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 317 location(s) · 89bio, Inc. · NCT06419374InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
Phase N/A · 3 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT04190849Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Phase 4 · 1 location(s) · Getz Pharma · NCT05644717Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT04371042Digoxin In NASH (CODIN)
Phase 2 · 2 location(s) · Yale University · NCT06588699Fibrosis Lessens After Metabolic Surgery
Phase 4 · 22 location(s) · Ali Aminian · NCT06374875"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chron
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04690972Liver Damage and Cardiometabolic Disorders in NAFLD
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04036357The European NAFLD Registry
Phase N/A · 37 location(s) · Newcastle University · NCT04442334Evaluating the Pharmacokinetics and Safety of Miricorilant
Phase 1 · 1 location(s) · Corcept Therapeutics · NCT07553663Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis
NA · 1 location(s) · University of Bologna · NCT06308757A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · 23 location(s) · King's College London · NCT06461208An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Cardiac Dysfunction in Patients with Fatty Liver Disease
Phase N/A · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06386094Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease
NA · 2 location(s) · Khyber Medical University Peshawar · NCT07294963Digital Early Warning System for Acute Lung Injury in Liver Surgery
Phase N/A · 1 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT07070362A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · 323 location(s) · Akero Therapeutics, Inc · NCT06528314Establishment of NAFLD Cohort and Development of Fibrosis Markers
Phase N/A · 1 location(s) · Seoul National University Boramae Hospital · NCT02206841Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Integrated Diagnostics for Early Diagnosis of Liver Disease
Phase N/A · 1 location(s) · Manchester University NHS Foundation Trust · NCT04666402Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Saint Pierre · NCT06814600A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis i
NA · 1 location(s) · University Hospital, Lille · NCT03472157CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
NA · 13 location(s) · University Hospital, Angers · NCT05699018
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.